云南白药
(000538)
| 流通市值：1005.58亿 | | | 总市值：1012.21亿 |
| 流通股本：17.73亿 | | | 总股本：17.84亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 16,794,818,737.97 | 14,218,343,076.67 | 13,086,769,626.75 | 12,545,694,750.39 |
| 应收票据及应收账款 | 11,906,951,872.4 | 10,193,713,019.77 | 10,971,086,396.36 | 10,404,305,767.95 |
| 其中：应收票据 | 326,870,742.68 | 227,542,572.56 | 1,214,032,652.02 | 741,097,162.68 |
| 应收账款 | 11,580,081,129.72 | 9,966,170,447.21 | 9,757,053,744.34 | 9,663,208,605.27 |
| 应收款项融资 | 1,796,192,110.12 | 1,590,749,810.74 | 934,281,420.64 | 634,158,821.4 |
| 预付款项 | 295,004,933.72 | 312,298,727.01 | 445,535,435.75 | 410,643,169.96 |
| 其他应收款合计 | 92,123,710.22 | 104,050,709.53 | 124,566,722.06 | 533,146,423.08 |
| 应收股利 | - | 4,531,100 | - | 406,032,345.56 |
| 存货 | 6,131,635,452.71 | 6,442,194,823.67 | 6,922,510,026.53 | 6,970,395,685.01 |
| 一年内到期的非流动资产 | 223,270,000 | 442,772,777.78 | - | - |
| 其他流动资产 | 1,700,273,036.45 | 2,862,076,217.2 | 2,759,017,103.85 | 1,230,209,819.11 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 39,074,382,317.12 | 36,315,565,849.93 | 35,530,489,472.85 | 34,269,578,693.08 |
| 非流动资产: | | | | |
| 长期股权投资 | 11,794,304,966.75 | 11,536,660,992.93 | 11,531,670,562.73 | 11,334,322,872.56 |
| 其他权益工具投资 | 71,745,000 | 71,745,000 | 71,745,000 | 71,745,000 |
| 其他非流动金融资产 | 304,649,395.35 | 324,674,379.63 | 335,523,176.02 | 391,447,063.97 |
| 投资性房地产 | 46,150,865.17 | 44,104,145.97 | 54,443,615.46 | 54,825,749.03 |
| 固定资产 | 2,615,033,299.65 | 2,662,900,014.03 | 2,653,256,337.21 | 2,639,966,624.79 |
| 在建工程 | 590,457,230.39 | 529,708,553.58 | 453,801,176.59 | 384,905,022.44 |
| 生产性生物资产 | 945,449.82 | 988,424.85 | 1,031,399.76 | 1,074,374.79 |
| 使用权资产 | 250,066,755.07 | 258,319,485.58 | 255,469,180.19 | 271,007,940.03 |
| 无形资产 | 577,476,016.88 | 583,372,000.59 | 590,498,257.06 | 592,851,437.55 |
| 开发支出 | 16,846,125.06 | 14,452,474.57 | 9,048,987.02 | 9,048,987.02 |
| 商誉 | 104,121,771.67 | 104,121,771.67 | 129,882,094.89 | 129,882,094.89 |
| 长期待摊费用 | 102,920,409.29 | 105,335,550.31 | 105,325,062.98 | 101,750,205.68 |
| 递延所得税资产 | 778,056,704.63 | 690,869,209.12 | 643,951,307.9 | 677,123,635.5 |
| 其他非流动资产 | 547,194,788.34 | 541,475,331.17 | 966,213,545.77 | 996,918,974.01 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 17,799,968,778.07 | 17,468,727,334 | 17,801,859,703.58 | 17,656,869,982.26 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 56,874,351,095.19 | 53,784,293,183.93 | 53,332,349,176.43 | 51,926,448,675.34 |
| 流动负债: | | | | |
| 短期借款 | 1,720,918,012.99 | 1,747,303,700.34 | 1,459,762,578.63 | 1,524,432,903.76 |
| 应付票据及应付账款 | 6,270,242,603.36 | 6,210,495,955.98 | 6,601,402,075.33 | 6,410,876,374.89 |
| 其中：应付票据 | 1,662,164,043.24 | 1,850,863,313.78 | 1,815,595,423.42 | 1,889,582,464.57 |
| 应付账款 | 4,608,078,560.12 | 4,359,632,642.2 | 4,785,806,651.91 | 4,521,293,910.32 |
| 预收款项 | 1,656,350.7 | 486,612.12 | 2,428,293.97 | 3,200,394.26 |
| 合同负债 | 1,744,645,110.54 | 1,739,865,228.75 | 1,462,134,202.32 | 1,553,057,007.25 |
| 应付职工薪酬 | 828,275,273.16 | 1,067,190,665.08 | 375,897,931.74 | 370,969,181.4 |
| 应交税费 | 541,054,705.28 | 339,670,850.02 | 502,528,333.61 | 474,549,435.58 |
| 其他应付款合计 | 1,267,870,752.46 | 1,025,085,879.54 | 1,410,535,104.5 | 1,340,766,834.05 |
| 应付股利 | 86,490,742.04 | 86,490,742.04 | 87,274,903.68 | 95,031,694.37 |
| 一年内到期的非流动负债 | 76,949,727.39 | 74,736,102.58 | 76,046,545.75 | 79,130,236.45 |
| 其他流动负债 | 1,675,888,673.02 | 532,943,904.4 | 464,782,048.3 | 468,011,160.68 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 14,127,501,208.9 | 12,737,778,898.81 | 12,355,517,114.15 | 12,224,993,528.32 |
| 非流动负债: | | | | |
| 长期借款 | 2,100,000 | 2,100,000 | 2,100,000 | 2,100,000 |
| 租赁负债 | 166,400,365.03 | 172,347,309.72 | 175,487,849.27 | 183,946,367.1 |
| 长期应付款 | 623,187,474.85 | 631,735,908.04 | 637,795,242.28 | 637,183,176.29 |
| 长期应付职工薪酬 | 4,067,521.85 | 4,090,687.99 | 4,112,886.51 | 4,236,056.04 |
| 递延收益 | 256,297,365.34 | 238,811,111.04 | 191,906,630.49 | 186,342,751.32 |
| 递延所得税负债 | 78,003,415.94 | 74,772,071.7 | 56,244,309.05 | 69,676,395.57 |
| 其他非流动负债 | 13,276,588.77 | 17,296,814.41 | 21,722,521.12 | 21,535,982.23 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,143,332,731.78 | 1,141,153,902.9 | 1,089,369,438.72 | 1,105,020,728.55 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 15,270,833,940.68 | 13,878,932,801.71 | 13,444,886,552.87 | 13,330,014,256.87 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,796,862,549 | 1,796,862,549 | 1,796,862,549 | 1,796,862,549 |
| 资本公积 | 18,246,693,041.24 | 18,246,619,742.09 | 18,234,685,648.45 | 18,237,265,189.86 |
| 减:库存股 | 707,428,892.15 | 707,428,892.15 | 707,428,892.15 | 707,428,892.15 |
| 其他综合收益 | -90,547,503.69 | -89,538,172.13 | -100,164,870.58 | -95,625,013.51 |
| 盈余公积 | 2,530,458,968.58 | 2,530,458,968.58 | 2,530,458,968.58 | 2,530,458,968.58 |
| 未分配利润 | 19,804,079,282.12 | 18,102,147,836.12 | 18,131,843,176.55 | 16,836,377,377.4 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 41,580,117,445.1 | 39,879,122,031.51 | 39,886,256,579.85 | 38,597,910,179.18 |
| 少数股东权益 | 23,399,709.41 | 26,238,350.71 | 1,206,043.71 | -1,475,760.71 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 41,603,517,154.51 | 39,905,360,382.22 | 39,887,462,623.56 | 38,596,434,418.47 |
| 负债和股东权益合计 | 56,874,351,095.19 | 53,784,293,183.93 | 53,332,349,176.43 | 51,926,448,675.34 |
| 公告日期 | 2024-04-27 | 2024-03-30 | 2023-10-31 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |